Loading clinical trials...
Loading clinical trials...
The purpose of this trial is to determine the efficacy and safety of A3384 administered to patients with Bile Acid Malabsorption (BAM)/Bile Acid Diarrhoea (BAD).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Albireo
NCT06609148 · Bile Acid Malabsorption, Bile Acid Diarrhea
NCT07429864 · HBV, HBV Coinfection, and more
NCT07338565 · Colitis Ulcerosa, Colitis Ulcerative, and more
NCT05130047 · Chronic Diarrhea, Irritable Bowel Syndrome With Diarrhea, and more
NCT02628626 · Fecal Incontinence, Bile Acid Malabsorption
Sahlgrenska Academy
Gothenburg
Kärnsjukhuset
Skövde
Hammersmith Hospital, Imperial College Healthcare NHS Trust
London
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions